Helen Millward

4.0k total citations
3 papers, 3 citations indexed

About

Helen Millward is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Helen Millward has authored 3 papers receiving a total of 3 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Helen Millward's work include Ubiquitin and proteasome pathways (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer therapeutics and mechanisms (1 paper). Helen Millward is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer therapeutics and mechanisms (1 paper). Helen Millward collaborates with scholars based in United States and United Kingdom. Helen Millward's co-authors include Elisa Fontana, Cara Mathews, Gottfried E. Konecny, Graeme C.M. Smith, Emre Karakoç, Carol Aghajanian, Ian C. P. Smith, Susanna V. Ulahannan, Bert H. O’Neil and Babar Bashir and has published in prestigious journals such as Cancer Research and Gynecologic Oncology.

In The Last Decade

Helen Millward

2 papers receiving 3 citations

Peers

Helen Millward

MB

ONCOL

CR

N Thejeswar India

Amrit Pipara India

Fabrice Barlesi France

Rachel Harford United Kingdom

J. Luo China

Jürgen Rolke Norway

Agnes Reschke United States

Ramaprasad Srinivasan United States

Alexandra Beck United Kingdom

J Jelenkovic Serbia

N Thejeswar India

Helen Millward

3 ×1.0

MB

3 ×1.0

ONCOL

0 ×0.0

CR

Citations per year, relative to Helen Millward Helen Millward (= 1×) peers N Thejeswar

Countries citing papers authored by Helen Millward

Since Specialization

Citations

This map shows the geographic impact of Helen Millward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Millward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Millward more than expected).

Fields of papers citing papers by Helen Millward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Millward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Millward. The network helps show where Helen Millward may publish in the future.

Co-authorship network of co-authors of Helen Millward

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Millward. A scholar is included among the top collaborators of Helen Millward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Millward. Helen Millward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Ulahannan, Susanna V., Jason T. Henry, Kathleen N. Moore, et al.. (2025). Abstract CT267: First results of ART0380 (an ATR kinase inhibitor) with low dose irinotecan in advanced or metastatic solid tumors. Cancer Research. 85(8_Supplement_2). CT267–CT267.

2.

Aghajanian, Carol, Kathleen N. Moore, Thomas C. Krivak, et al.. (2024). A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST). Gynecologic Oncology. 190. S296–S297. 1 indexed citations

3.

Patel, Manish R., Kathleen N. Moore, Jayesh B. Majithiya, et al.. (2022). Abstract LB520: A pharmacodynamic platform using liquid biopsy to support dose selection for the ATR inhibitor ART0380 (IACS-030380). Cancer Research. 82(12_Supplement). LB520–LB520. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact